Ryanne Early, Seed Biotech’s CEO was one of the co-authors of the Human Amniotic Membrane Enhanced Allograft Bone Graft submission, which was selected to be presented at the ORS 2019 Annual Meeting as a Late Breaking POSTER presentation !
Authors: Ryanne Early; Harold M. Aberman; Cameron Clokie
Seed Biotech, Inc. will be attending the North American Spine Society (NASS) annual conference, in Los Angeles, CA, from Sept. 26-29 2018.
Stop by our booth and learn more about our company and our products!
Seed Biotech, Inc. was present at the North American Spine Association (NASS) annual conference in Orlando, FL, from October 25-28 2017.
We were glad to meet so many great people and get to share more about what we do and our products.
Looking forward to next year's conference.
Seed Biotech, Inc. is happy to welcome Holly Hewitt to the team, as our Director of Continuous Improvement.
Glad to have you, Holly!
Seed Biotech, Inc. is expanding and has just opened a Sales and Marketing Department. Kirk Purswell will be joining the team as Director of Sales & Marketing. Exciting to have you, Kirk!
Seed Biotech, Inc. has received the accreditation for the Processing, Storage and Distribution of Musculoskeletal Tissue for Transplantation by the American Association of Tissue Banks (AATB).
Seed Biotech, Inc. is officially approved as a Tissue Bank for Comprehensive Tissue Procuremnt Service of Amniotic Membrane and as a Tissue Processing Facility for Amniotic Membrane by the New York State Department of Health.
Seed Biotech, Inc. is pleased to announce that we have recently delivered over 10,000 units of our Aril® grafts!!
Seed Biotech, Inc. is licensed to engaged in tissue bank operations by the State of California Department of Public Health.